{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T05:29:23Z","timestamp":1784784563760,"version":"3.55.0"},"reference-count":71,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Systemic autoinflammatory diseases (SAIDs) are defined by recurrent febrile attacks associated with protean manifestations involving joints, the gastrointestinal tract, skin, and the central nervous system, combined with elevated inflammatory markers, and are caused by a dysregulation of the innate immune system. From a clinical standpoint, the most known SAIDs are familial Mediterranean fever (FMF); cryopyrin-associated periodic syndrome (CAPS); mevalonate kinase deficiency (MKD); and periodic fever, aphthosis, pharyngitis, and adenitis (PFAPA) syndrome. Current guidelines recommend the regular sequential administration of vaccines for all individuals with SAIDs. However, these patients have a much lower vaccination coverage rates in \u2018real-world\u2019 epidemiological studies than the general population. The main purpose of this review was to evaluate the scientific evidence available on both the efficacy and safety of vaccines in patients with SAIDs. From this analysis, neither serious adverse effects nor poorer antibody responses have been observed after vaccination in patients with SAIDs on treatment with biologic agents. More specifically, no new-onset immune-mediated complications have been observed following immunizations. Post-vaccination acute flares were significantly less frequent in FMF patients treated with colchicine alone than in those treated with both colchicine and canakinumab. Conversely, a decreased risk of SARS-CoV-2 infection has been proved for patients with FMF after vaccination with the mRNA-based BNT162b2 vaccine. Canakinumab did not appear to affect the ability to produce antibodies against non-live vaccines in patients with CAPS, especially if administered with a time lag from the vaccination. On the other hand, our analysis has shown that immunization against Streptococcus pneumoniae, specifically with the pneumococcal polysaccharide vaccine, was associated with a higher incidence of adverse reactions in CAPS patients. In addition, disease flares might be elicited by vaccinations in children with MKD, though no adverse events have been noted despite concurrent treatment with either anakinra or canakinumab. PFAPA patients seem to be less responsive to measles, mumps, and rubella-vaccine, but have shown higher antibody response than healthy controls following vaccination against hepatitis A. In consideration of the clinical frailty of both children and adults with SAIDs, all vaccinations remain \u2018highly\u2019 recommended in this category of patients despite the paucity of data available.<\/jats:p>","DOI":"10.3390\/vaccines11010151","type":"journal-article","created":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T02:06:03Z","timestamp":1673402763000},"page":"151","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Current Evidence on Vaccinations in Pediatric and Adult Patients with Systemic Autoinflammatory Diseases"],"prefix":"10.3390","volume":"11","author":[{"given":"Maria Grazia","family":"Massaro","sequence":"first","affiliation":[{"name":"Department of Translational Medicine and Surgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5308-7072","authenticated-orcid":false,"given":"Mario","family":"Caldarelli","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and Surgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8638-7565","authenticated-orcid":false,"given":"Laura","family":"Franza","sequence":"additional","affiliation":[{"name":"Emergency Medicine Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8443-7880","authenticated-orcid":false,"given":"Marcello","family":"Candelli","sequence":"additional","affiliation":[{"name":"Emergency Medicine Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6230-1779","authenticated-orcid":false,"given":"Antonio","family":"Gasbarrini","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and Surgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy"},{"name":"Department of Translational Medicine and Surgery, Catholic University of the Sacred Heart, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Gambassi","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and Surgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy"},{"name":"Department of Translational Medicine and Surgery, Catholic University of the Sacred Heart, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5378-8442","authenticated-orcid":false,"given":"Rossella","family":"Cianci","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and Surgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy"},{"name":"Department of Translational Medicine and Surgery, Catholic University of the Sacred Heart, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7032-7779","authenticated-orcid":false,"given":"Donato","family":"Rigante","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and Surgery, Catholic University of the Sacred Heart, 00168 Rome, Italy"},{"name":"Department of Life Sciences and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"102421","DOI":"10.1016\/j.jaut.2020.102421","article-title":"Systemic autoinflammatory diseases","volume":"109","author":"Krainer","year":"2020","journal-title":"J. Autoimmun."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Sangiorgi, E., and Rigante, D. (2022). The clinical chameleon of autoinflammatory diseases in children. Cells, 11.","DOI":"10.3390\/cells11142231"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"485103","DOI":"10.1155\/2013\/485103","article-title":"From the Mediterranean to the sea of Japan: The transcontinental odyssey of autoinflammatory diseases","volume":"2013","author":"Rigante","year":"2013","journal-title":"Biomed Res. Int."},{"key":"ref_4","first-page":"474","article-title":"Familial Mediterranean fever without MEFV mutation: A challenging diagnosis","volume":"20","author":"Lopes","year":"2022","journal-title":"Skinmed"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1177\/039463201102400402","article-title":"Bridging the gap between the clinician and the patient with cryopyrin-associated periodic syndromes","volume":"24","author":"Cantarini","year":"2011","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.5152\/TurkArchPediatr.2022.21321","article-title":"Mevalonate kinase deficiency\/hyperimmunoglobulin D syndrome (MVK\/HIDS) in a differential diagnosis of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome and familial Mediterranean fever (FMF): A case report","volume":"57","author":"Kunter","year":"2022","journal-title":"Turk. Arch. Pediatr."},{"key":"ref_7","first-page":"1","article-title":"The protean visage of systemic autoinflammatory syndromes: A challenge for interprofessional collaboration","volume":"14","author":"Rigante","year":"2010","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Hashkes, P., Laxer, R., and Simon, A. (2019). Pattern recognition receptors in autoinflammation. Textbook of Autoinflammation, Springer.","DOI":"10.1007\/978-3-319-98605-0"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.lpm.2018.12.003","article-title":"Autoinflammatory diseases: State of the art","volume":"48","author":"Fayand","year":"2019","journal-title":"Presse Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/1744666X.2017.1280396","article-title":"A systematic approach to autoinflammatory syndromes: A spelling booklet for the beginner","volume":"13","author":"Rigante","year":"2017","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_11","first-page":"cm1","article-title":"Interleukin-1 (IL-1) pathway","volume":"3","author":"Weber","year":"2010","journal-title":"Sci. Signal"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/annrheumdis-2015-208690","article-title":"EULAR recommendations for the management of familial Mediterranean fever","volume":"75","author":"Ozen","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2478\/rir-2021-0028","article-title":"Systemic autoinflammatory disease and genetic testing","volume":"2","author":"Yao","year":"2021","journal-title":"Rheumatol. Immunol. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2147\/JMDH.S351546","article-title":"The added value of a multidisciplinary clinic for systemic autoinflammatory diseases","volume":"15","author":"Zinterl","year":"2022","journal-title":"J. Multidiscip. Healthc."},{"key":"ref_15","first-page":"339","article-title":"Cold-induced urticaria in children","volume":"19","author":"Guerriero","year":"2021","journal-title":"Skinmed"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/rheumatology\/kev416","article-title":"Real-life effectiveness of canakinumab in cryopyrin-associated periodic syndrome","volume":"55","author":"Hofer","year":"2016","journal-title":"Rheumatology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/21678707.2018.1406797","article-title":"A developing portrait of hereditary periodic fevers in childhood","volume":"6","author":"Rigante","year":"2018","journal-title":"Expert Opin. Orphan Drugs"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1172-1-13","article-title":"Mevalonate kinase deficiencies: From mevalonic aciduria to hyperimmunoglobulinemia D syndrome","volume":"1","author":"Haas","year":"2006","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s41232-022-00217-7","article-title":"Autoinflammatory disease: Clinical perspectives and therapeutic strategies","volume":"42","author":"Kawakami","year":"2022","journal-title":"Inflamm. Regen."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s11739-021-02751-7","article-title":"The everchanging framework of autoinflammation","volume":"6","author":"Manna","year":"2021","journal-title":"Intern. Emerg. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e2018067","DOI":"10.4084\/mjhid.2018.067","article-title":"The broad-ranging panorama of systemic autoinflammatory disorders with specific focus on acute painful symptoms and hematologic manifestations in children","volume":"10","author":"Rigante","year":"2018","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3899\/jrheum.170684","article-title":"Efficacy of continuous interleukin 1 blockade in mevalonate kinase deficiency: A multicenter retrospective study in 13 adult patients and literature review","volume":"45","author":"Deshayes","year":"2018","journal-title":"J. Rheumatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-3476(87)80285-8","article-title":"Syndrome of periodic fever, pharyngitis, and aphthous stomatitis","volume":"110","author":"Marshall","year":"1987","journal-title":"J. Pediatr."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"109830","DOI":"10.1016\/j.ijporl.2019.109830","article-title":"Periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome: A debate about diagnosis and treatment in children continues","volume":"130","author":"Rigante","year":"2020","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"6871","DOI":"10.2147\/IJGM.S373942","article-title":"PFAPA syndrome: Clinical, laboratory and therapeutic features in a single-centre cohort","volume":"15","author":"Lazea","year":"2022","journal-title":"Int. J. Gen. Med."},{"key":"ref_26","first-page":"e2021087","article-title":"Periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome in children: A brief literature review","volume":"40","author":"Okamoto","year":"2022","journal-title":"Rev. Paul. Pediatr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"111153","DOI":"10.1016\/j.ijporl.2022.111153","article-title":"A comparative study for the clinical features in children with PFAPA syndrome who were diagnosed before and after the age of five","volume":"158","author":"Demir","year":"2022","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/annrheumdis-2019-215882","article-title":"2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"79","author":"Furer","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/annrheumdis-2022-222574","article-title":"EULAR\/PRES recommendations for vaccination of paediatric patients with autoimmune inflammatory rheumatic diseases: Update 2021","volume":"82","author":"Jansen","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Plitnick, L., and Herzyk, D. (2013). Global regulatory guidelines for vaccines. Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics, Academic Press.","DOI":"10.1016\/B978-0-12-394810-6.00009-5"},{"key":"ref_31","unstructured":"Verma, A.S., and Singh, A. (2014). Vaccines: Present status and applications. Animal Biotechnology, Models in Discovery and Translation, Academic Press."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: From basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/cei.13287","article-title":"Novel approaches for the design, delivery and administration of vaccine technologies","volume":"196","author":"Wallis","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e2035693","DOI":"10.1001\/jamanetworkopen.2020.35693","article-title":"Immunogenicity and safety of reduced-dose intradermal vs intramuscular influenza vaccines: A systematic review and meta-analysis","volume":"4","author":"Egunsola","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"100242","DOI":"10.1016\/j.jvacx.2022.100242","article-title":"Reactogenicity and immunogenicity of the intradermal administration of BNT162b2 mRNA vaccine in healthy adults who were primed with an inactivated SARS-CoV-2 vaccine","volume":"12","author":"Temtanakitpaisan","year":"2022","journal-title":"Vaccine X"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e001035","DOI":"10.1136\/rmdopen-2019-001035","article-title":"Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: A systematic literature review for the 2019 update of EULAR recommendations","volume":"5","author":"Rondaan","year":"2019","journal-title":"RMD Open"},{"key":"ref_37","first-page":"421","article-title":"Vaccines in patients with primary immune deficiency","volume":"40","author":"Bonilla","year":"2020","journal-title":"Immunol. Allergy Clin."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nrrheum.2013.95","article-title":"Vaccinations in juvenile chronic inflammatory diseases: An update","volume":"9","author":"Silva","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1001\/jama.2013.6768","article-title":"Effects of the live attenuated measles-mumps-rubella booster vaccination on disease activity in patients with juvenile idiopathic arthritis: A randomized trial","volume":"309","author":"Heijstek","year":"2013","journal-title":"JAMA"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/j.vaccine.2020.01.037","article-title":"PRES working party of Vaccination Study Group. Live attenuated MMR\/V booster vaccines in children with rheumatic diseases on immunosuppressive therapy are safe: Multicenter, retrospective data collection","volume":"38","author":"Uziel","year":"2020","journal-title":"Vaccine"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12969-018-0231-3","article-title":"Varicella-zoster-virus vaccination in immunosuppressed children with rheumatic diseases using a pre-vaccination check list","volume":"16","author":"Speth","year":"2018","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1016\/j.vaccine.2017.04.015","article-title":"Varicella vaccination elicits a humoral and cellular response in children with rheumatic diseases using immune suppressive treatment","volume":"35","author":"Groot","year":"2015","journal-title":"Vaccine"},{"key":"ref_43","first-page":"16","article-title":"The safety of live-attenuated vaccines in patients using IL-1 or IL-6 blockade: An international survey","volume":"21","author":"Jeyaratnam","year":"2018","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2019.03.007","article-title":"Autoimmune\/inflammatory syndrome induced by adjuvants (ASIA) demonstrates distinct autoimmune and autoinflammatory disease associations according to the adjuvant subtype: Insights from an analysis of 500 cases","volume":"203","author":"Watad","year":"2019","journal-title":"Clin. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1128\/CVI.00175-10","article-title":"Influenza and meningococcal vaccinations are effective in healthy subjects treated with the interleukin-1 beta-blocking antibody canakinumab: Results of an open-label, parallel group, randomized, single-center study","volume":"17","author":"Chioato","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12969-021-00518-0","article-title":"Response to influenza vaccination in immunocompromised children with rheumatic disease: A prospective cohort study","volume":"19","author":"Jensen","year":"2021","journal-title":"Pediatr. Rheumatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/rheumatology\/keac123","article-title":"Antibody responses to inactivated and mRNA SARS-CoV-2 vaccines in familial Mediterranean fever patients treated with interleukin-1 inhibitors","volume":"28","author":"Ugurlu","year":"2022","journal-title":"Rheumatology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00296-022-05119-y","article-title":"Safety of SARS-CoV-2 vaccination in patients with Beh\u00e7et's syndrome and familial Mediterranean fever: A cross-sectional comparative study on the effects of m-RNA based and inactivated vaccine","volume":"42","author":"Ozdede","year":"2022","journal-title":"Rheumatol. Int."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/1756-185X.14349","article-title":"A single-center COVID-19 vaccine experience with CoronaVac and BNT162b2 in familial Mediterranean fever patients","volume":"25","author":"Atalar","year":"2022","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/rheumatology\/keac131","article-title":"Safety of the BNT162b2 mRNA COVID-19 vaccine in patients with familial Mediterranean fever","volume":"28","author":"Shechtman","year":"2022","journal-title":"Rheumatology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1186\/1546-0096-13-S1-P1","article-title":"Efficacy, safety and post-vaccination antibody titer data in children with CAPS treated with canakinumab","volume":"13","author":"Brogan","year":"2015","journal-title":"Pediatr. Rheumatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1136\/ard.2011.152728","article-title":"Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes","volume":"70","author":"Hachulla","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/rheumatology\/kex185","article-title":"Safety of vaccinations in patients with cryopyrin-associated periodic syndromes: A prospective registry-based study","volume":"56","author":"Jaeger","year":"2017","journal-title":"Rheumatology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/art.39482","article-title":"Brief report: Severe inflammation following vaccination against Streptococcus pneumoniae in patients with cryopyrin-associated periodic syndromes","volume":"68","author":"Walker","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.1016\/j.vaccine.2016.10.035","article-title":"Mumps, measles and rubella vaccination in children with PFAPA syndrome","volume":"34","author":"Szenborn","year":"2016","journal-title":"Vaccine"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/ped.13719","article-title":"Immunogenicity and side-effects of the inactivated hepatitis A vaccine in periodic fever, aphthous stomatitis, pharyngitis, and adenitis patients","volume":"61","author":"Maritsi","year":"2019","journal-title":"Pediatr. Int."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1007\/s10067-020-05553-y","article-title":"Suboptimal vaccination coverage of recommended vaccines among French children with recurrent autoinflammatory fever syndromes: A study from the Juvenile Inflammatory Rheumatism cohort","volume":"40","author":"Mirete","year":"2021","journal-title":"Clin. Rheumatol."},{"key":"ref_58","first-page":"260","article-title":"Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: Introducing a vaccination provocation model","volume":"63","author":"Bodar","year":"2005","journal-title":"Neth. J. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"106293","DOI":"10.1016\/j.phrs.2022.106293","article-title":"Clinical impact and disease evolution of SARS-CoV-2 infection in familial Mediterranean fever","volume":"182","author":"Marinelli","year":"2022","journal-title":"Pharmacol. Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(21)01429-X","article-title":"Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): Interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey","volume":"398","author":"Tanriover","year":"2021","journal-title":"Lancet"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1056\/NEJMoa2027906","article-title":"Safety and immunogenicity of two RNA-based COVID-19 vaccine candidates","volume":"383","author":"Walsh","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Bettiol, A., Lopalco, G., Emmi, G., Cantarini, L., Urban, M.L., Vitale, A., Denora, N., Lopalco, A., Cutrignelli, A., and Lopedota, A. (2019). Unveiling the efficacy, safety, and tolerability of anti-interleukin-1 treatment in monogenic and multifactorial autoinflammatory diseases. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20081898"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/03009740310003974","article-title":"Etanercept induces improvement of arthropathy in chronic infantile neurological cutaneous articular (CINCA) syndrome","volume":"32","author":"Federico","year":"2003","journal-title":"Scand. J. Rheumatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.cell.2010.03.002","article-title":"Autoinflammatory disease reloaded: A clinical perspective","volume":"140","author":"Kastner","year":"2010","journal-title":"Cell"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"22777","DOI":"10.1038\/s41598-021-02321-z","article-title":"Comparing the clinical efficacy of COVID-19 vaccines: A systematic review and network meta-analysis","volume":"11","author":"Rotshild","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_66","first-page":"102898","article-title":"Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review","volume":"13","author":"Rojas","year":"2022","journal-title":"J. Autoimmun."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Hayashi, T., Ichikawa, M., and Konishi, I. (2022). Spontaneous myocarditis in mice predisposed to autoimmune disease: Including vaccination-induced onset. Biomedicines, 10.","DOI":"10.1101\/2022.03.14.484354"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Hajjo, R., Sabbah, D.A., Bardaweel, S.K., and Tropsha, A. (2021). Shedding the light on post-vaccine myocarditis and pericarditis in COVID-19 and non-COVID-19 vaccine recipients. Vaccines, 9.","DOI":"10.3390\/vaccines9101186"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1056\/NEJMoa2110737","article-title":"Myocarditis after COVID-19 vaccine in a large health care organization","volume":"385","author":"Witberg","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.molimm.2019.07.012","article-title":"Macrophage NLRP3 inflammasome activated by CVB3 capsid proteins contributes to the development of viral myocarditis","volume":"114","author":"Bao","year":"2019","journal-title":"Mol. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.autrev.2013.07.007","article-title":"Influenza and pneumococcal vaccinations of patients with systemic lupus erythematosus: Current views upon safety and immunogenicity","volume":"13","author":"Murdaca","year":"2014","journal-title":"Autoimmun. Rev."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/1\/151\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:06:13Z","timestamp":1760119573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/1\/151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["vaccines11010151"],"URL":"https:\/\/doi.org\/10.3390\/vaccines11010151","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,10]]}}}